Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome

Annals of Neurology

Volumn 30, Issue 4, 1991, Pages 558-562

  Singer, Harvey S ^a   Hahn, In‐Hei ^a   Moran, Timothy H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CINANSERIN; DOPAMINE; FLUPHENAZINE; HALOPERIDOL; HOMOVANILLIC ACID;

ADULT; ARTICLE; CASE REPORT; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

3,4-DIHYDROXYPHENYLACETIC ACID; ADULT; CAUDATE NUCLEUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; FEMALE; HOMOVANILLIC ACID; HUMAN; IN VITRO; KINETICS; MALE; MIDDLE AGE; PUTAMEN; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TOURETTE SYNDROME;

EID: 0025938404     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410300408     Document Type: Article

References (32)

1. Pathobiology of Tourette's syndrome
2. Tourette syndrome and other tic disorders: diagnosis, pathophysiology and treatment
3. Biogenic amine metabolism in Tourette syndrome
4. Dopaminergic dysfunction in Tourette syndrome
5. Tourette syndrome: a neurochemical analysis of postmortem cortical brain tissue
6. Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome
7. Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment
8. Effects of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome
9. Presynaptic catecholamine antagonists as treatment for Tourette syndrome: effects of alpha‐methyl‐para‐tyrosine and tetrabenazine
10. Gilles de la Tourette syndrome after long‐term chlorpromazine therapy
11. The relationship between stimulant medication and tics
12. Chronic, multiple tics of Gilles de la Tourette's disease: CSF acid monoamine metabolites after probenecid administration
13. 3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites
14. 3H‐SCH 23390, a selective D‐1 receptor antagonist ligand, in rat striatum
15. 3H]spiroperidol on rat striatal membranes
16. Protein measurement with the Folin phenol reagent
17. Rapid and simple method for measuring biogenic amines and metabolites in brain homogenates by HPLC‐electrochemical detection
18. A simple and sensitive saturation assay method for the measurement of adenosine 3′,5′‐cyclic monophosphate
19. 3H]Mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes
20. 3H]mazindol autoradiography
21. Striatal dopamine innervation and receptor density: regional effects of the weaver mutation
22. In vivo neurochemical and anatomical heterogeneity of the dopamine uptake system in the rat caudate putamen
23. Cocaine binding sites located in striatal membranes are regulatory sites for dopaminergic synapses
24. Chronic Ldeprenyl‐induced upregulation of the dopamine uptake carrier
25. Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia
26. 3H]GBR 12935 binding to dopamine uptake sites in schizophrenia
27. Desipramine binding: relationship to central and sympathetic noradrenergic activity
28. 3H]GBR‐12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's disease
29. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain
30. Insights into the pathophysiology and pathogenesis of Gilles de la Tourette syndrome